Company Filing History:
Years Active: 2015-2019
Title: Iannis Aifantis: Innovator in Cancer Treatment
Introduction
Iannis Aifantis is a prominent inventor based in Brooklyn, NY (US). He has made significant contributions to the field of cancer treatment, particularly in the development of innovative methods for addressing various types of leukemia. With a total of 4 patents to his name, Aifantis continues to push the boundaries of medical research.
Latest Patents
Aifantis's latest patents include groundbreaking methods for treating T-cell acute lymphoblastic leukemia (T-ALL). The first patent focuses on administering an inhibitor of jumonji D3 (JMJD3) demethylase to treat T-ALL. Another embodiment of this invention involves inhibiting T-ALL cell proliferation and survival through the same mechanism. Additionally, he has developed methods involving Notch receptor agonists for the treatment and prevention of acute myeloid leukemia and its relapse.
Career Highlights
Iannis Aifantis is affiliated with New York University, where he conducts his research and develops his innovative treatments. His work has garnered attention in the medical community, and he is recognized for his contributions to cancer research.
Collaborations
Aifantis collaborates with notable colleagues, including Camille Lobry and Linsey Reavie. Their combined expertise enhances the research efforts in the field of oncology.
Conclusion
Iannis Aifantis is a key figure in the advancement of cancer treatment methodologies. His innovative patents and collaborations reflect his commitment to improving patient outcomes in the fight against leukemia.